Li Xiang, Qin Ling, Dai Shi-kun, Jiang Shu-mei, Liu Zhi-heng
Guangdong Key Lab of Marine Materia Medica, South China Sea Institute of Oceanology, Chinese Academy of Sciences, Guangzhou 510301, China.
Wei Sheng Wu Xue Bao. 2007 Jun;47(3):548-53.
Preliminary statistics showed that there are more than one million species of microbes in marine environments that formed a dynamic genetic reservoir, among which the majority are not revealed and categorized due to barrier in cultivation techniques. However, the situation has changed in recent years because of the rapid development of phylogenetic studies based on small ribosomal RNA and rDNA sequencing independent to standard laboratory cultivation. These changes have significantly altered our understanding about microbial diversity and microbial ecology. In this review, we highlight some of recent progress and innovation in research on microbial diversity, and propose a metagenomic scheme as an alternative to overcome some of the barriers that still remain for exploitation of marine microbial diversity for its enormous potential in pharmaceutical applications. We believe that rapid progress in marine metagenomics allows direct access to the genomes of numerous non-cultivable microorganisms for their associated chemical prosperity.
初步统计表明,海洋环境中有超过100万种微生物,它们形成了一个动态的基因库,其中大多数由于培养技术的障碍而未被揭示和分类。然而,近年来情况有所改变,这是由于基于小核糖体RNA和rDNA测序的系统发育研究的迅速发展,这些研究独立于标准实验室培养。这些变化显著改变了我们对微生物多样性和微生物生态学的理解。在本综述中,我们重点介绍了微生物多样性研究中的一些最新进展和创新,并提出了一种宏基因组学方案,作为克服一些仍然存在的障碍的替代方法,以便利用海洋微生物多样性在制药应用中的巨大潜力。我们相信,海洋宏基因组学的快速进展使我们能够直接获取众多不可培养微生物的基因组,以了解它们相关的化学特性。